|
1
|
Smoller BR: Squamous cell carcinoma: From
precursor lesions to high-risk variants. Mod Pathol. 19(Suppl 2):
S88–S92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bowen GM, White GL Jr and Gerwels JW: Mohs
micrographic surgery. Am Fam Physician. 72:845–848. 2005.PubMed/NCBI
|
|
3
|
Serru V, Dessen P, Boucheix C and
Rubinstein E: Sequence and expression of seven new tetraspans.
Biochim Biophys Acta. 1478:159–163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: Molecular facilitators. FASEB J.
11:428–442. 1997.PubMed/NCBI
|
|
5
|
Yauch RL and Hemler ME: Specific
interactions among transmembrane 4 superfamily (TM4SF) proteins and
phosphoinositide 4-kinase. Biochem J. 351:629–637. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen L, Wang JL, Li H, Qin J and Wu YY:
Functions of NET-1 gene in skin squamous cell carcinoma cell line
(A431): A siRNA study. Zhonghua Bing Li Xue Za Zhi. 38:691–696.
2009.In Chinese.
|
|
7
|
Chen L, Li X, Wang GL, Wang Y, Zhu YY and
Zhu J: Clinicopathological significance of overexpression of
TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori. 94:531–538.
2008.PubMed/NCBI
|
|
8
|
Wollscheid V, Kühne-Heid R, Stein I,
Jansen L, Köllner S, Schneider A and Dürst M: Identification of a
new proliferation-associated protein NET-1/C4.8 characteristic for
a subset of high-grade cervical intraepithelial neoplasia and
cervical carcinomas. Int J Cancer. 99:771–775. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Zhu YY, Zhang XJ, Wang GL, Li XY,
He S, Zhang JB and Zhu JW: TSPAN1 protein expression: A significant
prognostic indicator for patients with colorectal adenocarcinoma.
World J Gastroenterol. 15:2270–2276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Scholz CJ, Kurzeder C, Koretz K, Windisch
J, Kreienberg R, Sauer G and Deissler H: Tspan-1 is a tetraspanin
preferentially expressed by mucinous and endometrioid subtypes of
human ovarian carcinomas. Cancer Lett. 275:198–203. 2009.
View Article : Google Scholar
|
|
11
|
Chen L, Zhu Y, Li H, Wang GL, Wu YY, Lu
YX, Qin J, Tuo J, Wang JL and Zhu J: Knockdown of TSPAN1 by RNA
silencing and antisense technique inhibits proliferation and
infiltration of human skin squamous carcinoma cells. Tumori.
96:289–295. 2010.PubMed/NCBI
|
|
12
|
Kim GY, Lim SJ and Kim YW: Expression of
HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR
stabilizes cyclooxy-genase-2 in squamous cell carcinomas. Mod
Pathol. 24:1336–1347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ryan BM, O’Donovan N and Duffy MJ:
Survivin: A new target for anti-cancer therapy. Cancer Treat Rev.
35:553–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng K and Mahato RI: Gene modulation for
treating liver fibrosis. Crit Rev Ther Drug Carrier Syst.
24:93–146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mahato RI, Cheng K and Guntaka RV:
Modulation of gene expression by antisense and antigene
oligodeoxynucleotides and small interfering RNA. Expert Opin Drug
Deliv. 2:3–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Wang Z, Zhan X, Li DC, Zhu YY and
Zhu J: Association of NET-1 gene expression with human
hepatocellular carcinoma. Int J Surg Pathol. 15:346–353. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zaffaroni N, Pennati M and Daidone MG:
Survivin as a target for new anticancer interventions. J Cell Mol
Med. 9:360–372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu JB, Fu HQ, Huang LZ, Liu AW and Zhang
JX: Effects of siRNA-targeting BMP-2 on the abilities of migration
and invasion of human liver cancer SMMC7721 cells and its
mechanism. Cancer Gene Ther. 18:20–25. 2011. View Article : Google Scholar
|
|
19
|
Chen SM, Wang Y, Xiao BK and Tao ZZ:
Effect of blocking VEGF, hTERT and Bcl-xl by multiple shRNA
expression vectors on the human laryngeal squamous carcinoma
xenograft in nude mice. Cancer Biol Ther. 7:734–739. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi H and Shibuya M: The vascular
endothelial growth factor (VEGF)/VEGF receptor system and its role
under physiological and pathological conditions. Clin Sci.
109:227–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamada S, Yanamoto S, Kawasaki G, Mizuno A
and Nemoto TK: Overexpression of cortactin increases invasion
potential in oral squamous cell carcinoma. Pathol Oncol Res.
16:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu KF, Lin CK, Yu CP, Tzao C, Lee SC, Lee
YY, Tsai WC and Jin JS: Cortactin, fascin, and survivin expression
associated with clinicopathological parameters in esophageal
squamous cell carcinoma. Dis Esophagus. 22:402–408. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thomas S, Quinn BA, Das SK, Dash R, Emdad
L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, et al:
Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther
Targets. 17:61–75. 2013. View Article : Google Scholar
|
|
24
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et
al: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong SY and Seol DW: The role of
mitochondria in apoptosis. BMB Rep. 41:11–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
